OX2 THERAPEUTICS, INC.

Profile

Company Names

OX2 THERAPEUTICS, INC.

Addresses

1621 E. HENNEPIN AVENUE, SUITE 290, MINNEAPOLIS, MN 55414

5138 HANOVER DRIVE, MOUND, MN 55364

Phone Numbers

612-309-7653

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2016

State Incorporated:

DELAWARE

Total Amount Raised:

$954,417.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2020-08-20 
$649,415.00 
$750,007.00 
$100,592.00 
Equity 
1
2017-03-29 
$305,002.00 
$3,060,997.00 
$2,755,995.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
SUMANT 
 
DHAWAN 
EXECUTIVE OFFICER, DIRECTOR
OX2 THERAPEUTICS, INC.
ANDREA 
 
HUNT 
DIRECTOR
OX2 THERAPEUTICS, INC.
JEFF 
 
LITER 
EXECUTIVE OFFICER, PROMOTER
B-MOGEN BIOTECHNOLOGIES, INC.   |  OX2 THERAPEUTICS, INC.   |  LUMINARY THERAPEUTICS, INC.
THOMAS 
 
MARTINSON 
DIRECTOR
OX2 THERAPEUTICS, INC.
CHRISTOPHER 
 
MOERTEL 
EXECUTIVE OFFICER, DIRECTOR
OX2 THERAPEUTICS, INC.
BEN 
 
OEHLER 
DIRECTOR
AGRICULTURAL SOLUTIONS INC   |  OX2 THERAPEUTICS, INC.
MIKE 
 
OLIN 
EXECUTIVE OFFICER, DIRECTOR
OX2 THERAPEUTICS, INC.
ROB 
 
PARISH 
DIRECTOR
OX2 THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2020-09-21
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-08-20 
2017-05-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-03-29 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#